RHUMBLINE ADVISERS - JUNO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$2,830,000
+4.4%
61,919
+2.5%
0.01%0.0%
Q3 2017$2,711,000
+52.0%
60,426
+1.3%
0.01%
+50.0%
Q2 2017$1,783,000
+15.6%
59,642
-14.2%
0.00%0.0%
Q1 2017$1,542,000
+24.7%
69,486
+5.9%
0.00%
+33.3%
Q4 2016$1,237,000
-31.1%
65,633
+9.7%
0.00%
-40.0%
Q3 2016$1,795,000
-15.6%
59,813
+8.1%
0.01%
-16.7%
Q2 2016$2,128,000
+421.6%
55,351
+417.1%
0.01%
+500.0%
Q1 2016$408,000
-15.4%
10,704
-2.3%
0.00%
-50.0%
Q4 2015$482,000
+13.9%
10,954
+5.5%
0.00%
+100.0%
Q3 2015$423,000
-18.7%
10,384
+6.5%
0.00%
-50.0%
Q2 2015$520,0009,7470.00%
Other shareholders

There were no reported owners of JUNO THERAPEUTICS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of JUNO THERAPEUTICS INC shareholders